PIK3CG and cardiovascular disorder: In addition to the consideration of PI3Ks as therapeutic targets for cardiovascular disease, it is clearly also important to consider the significance of their inhibition in cardiovascular tissues as an unintended consequence of PI3K inhibitor administration in other settings, such as oncology.